.
MergerLinks Header Logo

Announced

Completed

Sanisure completed the acquisition of Medical Elastomer Development from 3i Group-backed Q Holding.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

Acquisition

Domestic

Specialty Chemicals

Completed

Majority

Private

synthetic rubber

Private Equity

Single Bidder

United States

Synopsis

Edit

Sanisure, a bioprocessing technology company, completed the acquisition of Medical Elastomer Development, a silicone extrusion company, from 3i Group-backed Q Holding, a global manufacturer of highly-engineered medical devices. Financial terms were not disclosed. "We are excited to have the MED Twinsburg Team joining Sanisure's growing family. We continue to invest in critical technologies and capabilities that drive innovation and supply security for our global customer base. State-of- the-art silicone extrusion capabilities are core to our portfolio of fluid management products and solutions, and enable us to provide both high quality silicone tubing and vertically integrated bioprocessing single-use solutions to our customers," Steven Chevillotte, Sanisure CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US